Global and Region Metabotropic Glutamate Receptor 5 Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Metabotropic Glutamate Receptor 5 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Metabotropic Glutamate Receptor 5market, defines the market attractiveness level of Metabotropic Glutamate Receptor 5 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Metabotropic Glutamate Receptor 5 industry, describes the types of Metabotropic Glutamate Receptor 5 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metabotropic Glutamate Receptor 5 market and the development prospects and opportunities of Metabotropic Glutamate Receptor 5 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metabotropic Glutamate Receptor 5 market in Chapter 13.

    By Player:

    • Eli Lilly and Company

    • Addex Therapeutics Ltd

    • Heptares Therapeutics Ltd

    • Novartis AG

    • Richter Gedeon Nyrt

    • Merz Pharma GmbH & Co KgaA

    • Toray Industries Inc

    • Bristol-Myers Squibb Company

    • Johnson & Johnson

    • Eisai Co Ltd

    • Sumitomo Dainippon Pharma Co Ltd

    • Aevi Genomic Medicine Inc

    By Type:

    • Alloswitch-1

    • BMS-952048

    • BMS-955829

    • Dipraglurant ER

    • Others

    By End-User:

    • Major Depressive Disorder

    • Alcohol Addiction

    • Alzheimer's Disease

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Metabotropic Glutamate Receptor 5 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Metabotropic Glutamate Receptor 5 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Metabotropic Glutamate Receptor 5 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Metabotropic Glutamate Receptor 5 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Metabotropic Glutamate Receptor 5 Market Analysis and Outlook to 2022

    • 7.1 Global Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    • 7.2 United States Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    • 7.3 Europe Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    • 7.4 China Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    • 7.5 Japan Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    • 7.6 India Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    • 7.7 South Korea Metabotropic Glutamate Receptor 5 Consumption (2017-2022)

    8 Region and Country-wise Metabotropic Glutamate Receptor 5 Market Analysis and Outlook to 2028

    • 8.1 Global Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    • 8.2 United States Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    • 8.3 Europe Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    • 8.4 China Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    • 8.5 Japan Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    • 8.6 India Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    • 8.7 South Korea Metabotropic Glutamate Receptor 5 Consumption Forecast (2022-2028)

    9 Global Metabotropic Glutamate Receptor 5 Market Outlook by Types and Applications to 2022

    • 9.1 Global Metabotropic Glutamate Receptor 5 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Alloswitch-1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global BMS-952048 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global BMS-955829 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Dipraglurant ER Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Metabotropic Glutamate Receptor 5 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Major Depressive Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Alcohol Addiction Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Metabotropic Glutamate Receptor 5 Market Outlook by Types and Applications to 2028

    • 10.1 Global Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Alloswitch-1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global BMS-952048 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global BMS-955829 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Dipraglurant ER Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Major Depressive Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Alcohol Addiction Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Metabotropic Glutamate Receptor 5 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Metabotropic Glutamate Receptor 5 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Metabotropic Glutamate Receptor 5 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Metabotropic Glutamate Receptor 5 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Metabotropic Glutamate Receptor 5 Market Competitive Analysis

    • 14.1 Eli Lilly and Company

      • 14.1.1 Eli Lilly and Company Company Details

      • 14.1.2 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product and Service

    • 14.2 Addex Therapeutics Ltd

      • 14.2.1 Addex Therapeutics Ltd Company Details

      • 14.2.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • 14.3 Heptares Therapeutics Ltd

      • 14.3.1 Heptares Therapeutics Ltd Company Details

      • 14.3.2 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • 14.4 Novartis AG

      • 14.4.1 Novartis AG Company Details

      • 14.4.2 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG Metabotropic Glutamate Receptor 5 Product and Service

    • 14.5 Richter Gedeon Nyrt

      • 14.5.1 Richter Gedeon Nyrt Company Details

      • 14.5.2 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product and Service

    • 14.6 Merz Pharma GmbH & Co KgaA

      • 14.6.1 Merz Pharma GmbH & Co KgaA Company Details

      • 14.6.2 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product and Service

    • 14.7 Toray Industries Inc

      • 14.7.1 Toray Industries Inc Company Details

      • 14.7.2 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product and Service

    • 14.8 Bristol-Myers Squibb Company

      • 14.8.1 Bristol-Myers Squibb Company Company Details

      • 14.8.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product and Service

    • 14.9 Johnson & Johnson

      • 14.9.1 Johnson & Johnson Company Details

      • 14.9.2 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product and Service

    • 14.10 Eisai Co Ltd

      • 14.10.1 Eisai Co Ltd Company Details

      • 14.10.2 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • 14.11 Sumitomo Dainippon Pharma Co Ltd

      • 14.11.1 Sumitomo Dainippon Pharma Co Ltd Company Details

      • 14.11.2 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • 14.12 Aevi Genomic Medicine Inc

      • 14.12.1 Aevi Genomic Medicine Inc Company Details

      • 14.12.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Metabotropic Glutamate Receptor 5

    • Figure Metabotropic Glutamate Receptor 5 Picture

    • Table Global Metabotropic Glutamate Receptor 5 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metabotropic Glutamate Receptor 5 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metabotropic Glutamate Receptor 5 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Metabotropic Glutamate Receptor 5 Consumption by Country (2017-2022)

    • Figure United States Metabotropic Glutamate Receptor 5 Consumption and Growth Rate (2017-2022)

    • Table Europe Metabotropic Glutamate Receptor 5 Consumption and Growth Rate (2017-2022)

    • Figure China Metabotropic Glutamate Receptor 5 Consumption and Growth Rate (2017-2022)

    • Figure Japan Metabotropic Glutamate Receptor 5 Consumption and Growth Rate (2017-2022)

    • Figure India Metabotropic Glutamate Receptor 5 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Metabotropic Glutamate Receptor 5 Consumption and Growth Rate (2017-2022)

    • Figure Global Metabotropic Glutamate Receptor 5 Consumption Forecast by Country (2022-2028)

    • Figure United States Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Metabotropic Glutamate Receptor 5 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alloswitch-1 Consumption and Growth Rate (2017-2022)

    • Figure Global BMS-952048 Consumption and Growth Rate (2017-2022)

    • Figure Global BMS-955829 Consumption and Growth Rate (2017-2022)

    • Figure Global Dipraglurant ER Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Major Depressive Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Alcohol Addiction Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alloswitch-1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BMS-952048 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BMS-955829 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dipraglurant ER Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Major Depressive Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alcohol Addiction Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Metabotropic Glutamate Receptor 5 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Metabotropic Glutamate Receptor 5 Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product and Service

    • Table Addex Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • Table Heptares Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Metabotropic Glutamate Receptor 5 Product and Service

    • Table Richter Gedeon Nyrt (Foundation Year, Company Profile and etc.)

    • Table Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product and Service

    • Table Merz Pharma GmbH & Co KgaA (Foundation Year, Company Profile and etc.)

    • Table Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product and Service

    • Table Toray Industries Inc (Foundation Year, Company Profile and etc.)

    • Table Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toray Industries Inc Metabotropic Glutamate Receptor 5 Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Metabotropic Glutamate Receptor 5 Product and Service

    • Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • Table Sumitomo Dainippon Pharma Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product and Service

    • Table Aevi Genomic Medicine Inc (Foundation Year, Company Profile and etc.)

    • Table Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.